Title : Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel.

Pub. Date : 2018 Oct 16

PMID : 30326862






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We aimed to evaluate whether PBBPs could have predictive value in HER2-positive ABC treated with pertuzumab and trastuzumab (PT) combined with eribulin (ERI) or nab-paclitaxel (Nab-PTX). Platinum erb-b2 receptor tyrosine kinase 2 Homo sapiens